In vivo effects of the 5‐HT6 antagonist SB‐271046 on striatal and frontal cortex extracellular concentrations of noradrenaline, dopamine, 5‐HT, glutamate and aspartate
Open accessThe DOI matches its Crossref record.
Abstract
Although the 5‐HT 6 receptor subtype was identified some 5 years ago, very little is known about its function within the brain. Here we demonstrate, for the first time, the neurochemical effects of a selective 5‐HT 6 receptor ligand. Using in vivo microdialysis in the freely moving rat, we evaluated the effects of the selective 5‐HT 6 receptor antagonist SB‐271046 by simultaneous measurement of 5‐hydroxytryptamine (5‐HT), dopamine (DA), noradrenaline (NA), glutamate and aspartate from the striatum and frontal cortex. SB‐271046 did not alter basal levels of 5‐HT, DA and NA in either brain region. Similarly, there was no change basal levels of either of the excitatory amino acids within the striatum. In contrast, administration of SB‐271046 (10 mg kg−1 s.c.) produced a significant (P<0.05), tetrodotoxin‐dependent, increase in extracellular levels of both glutamate and aspartate within the frontal cortex, reaching maximum values of 375.4±82.3 and 215.3±62.1% of preinjection values, respectively. British Journal of Pharmacology (2000) 130, 23–26; doi:10.1038/sj.bjp.0703288
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Millan, M. J. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00009-6 · Cited by 3,035
Proteinase-activated Receptors
(2006) · Encyclopedic Reference of Molecular Pharmacology · doi:10.1007/3-540-29832-0_1335 · Cited by 1,137
The neurobiology and control of anxious states
Millan, M. J. (2003) · Progress in Neurobiology · doi:10.1016/s0301-0082(03)00087-x · Cited by 965
Nichols, D. E., & Nichols, C. D. (2008) · Chemical Reviews · doi:10.1021/cr078224o · Cited by 895
Serotonin control of sleep-wake behavior
Monti, J. M. (2011) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2010.11.003 · Cited by 614
Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 551
Marek, G. J., Carpenter, L. L., McDougle, C. J., & Price, L. H. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300057 · Cited by 275
“In contrast, blockade of 5-HT6 receptors has recently been shown to increase extracellular levels of glutamate measured using in vivo dialysis in the prefrontal cortex, hippocampus, and striatum (Dawson et al, 2000, 2001).”
BackgroundRoth, B., Hanizavareh, S. M., & Blum, A. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1683-8 · Cited by 257
5-HT6 Receptor Antagonists as Novel Cognitive Enhancing Agents for Alzheimer's Disease
Upton, N., Chuang, T. T., Hunter, A. J., & Virley, D. J. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2008.05.008 · Cited by 255
Schechter, L. E., Lin, Q., Smith, D. L., Zhang, G., Shan, Q., Platt, B., Brandt, M. R., Dawson, L. A., Cole, D., Bernotas, R., et al. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301503 · Cited by 222
“Subsequent microdialysis studies actually showed that systemic administration of a 5-HT6 antagonist produced a two- and three-fold increase in basal glutamate levels in the rat hippocampus and frontal cortex, respectively (Dawson et al, 2000, 2001; Woolley et al, 2000).”
Self-citationThe neurochemistry of waking and sleeping mental activity: the disinhibition-dopamine hypothesis
GOTTESMANN, C. (2002) · Psychiatry and Clinical Neurosciences · doi:10.1046/j.1440-1819.2002.01022.x · Cited by 69
Metadata
- Authors
- Dawson, L. A., Nguyen, H. Q., & Li, P.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2000-05
- Volume
- 130
- Issue
- 1
- Pages
- 23-26
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2095460819
- Cited by
- 134
- References
- 0
- FWCI
- 3.43
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.